Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214883 · ClinicalTrials.gov registry record
UCF MammoChat: Image Repository
A clinical trial of Breast Cancer and Breast Cancer Female, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT07214883: Recruiting study of Breast Cancer and Breast Cancer Female, sponsored by University of Central Florida.
NCT07214883 is a study of Breast Cancer and Breast Cancer Female that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 20,000 participants, above the 2,787-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (618% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07214883, a study of Breast Cancer and Breast Cancer Female, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes. This study also aims to provide mammography images to participants.
Primary Outcome
Train, test and validate AI models with de-identified mammograms collected from imaging facilities.
Conditions Studied
Interventions
- OTHER No Interventions
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2025-09-03 |
| Est. Completion | 2026-06-30 |
What NCT07214883 shows while recruiting
NCT07214883 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,787-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (618% higher).
The record links to 6 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which No Interventions is the first listed.
NCT07214883 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07214883 about?
NCT07214883 is a clinical study titled "UCF MammoChat: Image Repository". This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes. This study also aims to provide mammography images to part...
What is the current status of trial NCT07214883?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2025-09-03. Estimated completion is 2026-06-30.
What conditions does trial NCT07214883 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Female, Breast Cancer Survivors, Breast Cancer Detection, Breast Cancer Awareness.
What interventions are being tested in trial NCT07214883?
The interventions under investigation include: No Interventions (OTHER).
Who is sponsoring clinical trial NCT07214883?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07214883 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07214883's enrollment target sits among peer trials
20,000 11th of 1224 higher than 1,214 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI